Press ReleaseThe Parisian Macao Celebrates 10th Anniversary Demonstrating Sands China’s long-term commitment to investing in Continuously expanding non-gaming offerings to… CISION PRNewswireSeptember 10, 2026
Press ReleaseAPR Takes Flagship Brand Medicube on U.S. and European Pop-Up Tour APR launches "Medicube Wellness Club X2" pop-ups across New York, Los Angeles,… CISION PRNewswireSeptember 10, 2026
Aircom Appoints Khurram Chaudhry as General Manager Long-time Aircom executive to lead the next phase of growth and AI… CISION PRNewswireSeptember 10, 2026
Press ReleaseZEISS announces commercial availability of bitoric hydrophobic monofocal IOL – the ZEISS AT LUCIA toric 721P Launching at ESCRS in London, the world’s first bitoric hydrophobic monofocal intraocular… CISION PRNewswireSeptember 10, 2026
IBM and NASA Release Open-Source AI Model to Support Lunar Exploration The NASA‑IBM Lunar Foundation Model turns decades of lunar observations into a… CISION PRNewswireSeptember 10, 2026
Students Rebuild Launches Protect Our Planet, Turning Youth Creativity Into $1 Million for the Planet Global Project to Donate $5 for Every Submission LOS ANGELES, Sept. 10,… CISION PRNewswireSeptember 10, 2026
Talogy assessment tool recognized for its contribution to building workplace resilience New book on resilience, written by leading experts on the psychology of… CISION PRNewswireSeptember 10, 2026
TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection — Phase IIb multicenter trial initiated, bringing this potential life-changing therapy closer… CISION PRNewswireSeptember 10, 2026